IC
LLY icon

IEQ Capital’s Eli Lilly LLY Stock Holding History

IEQ Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128M Sell
106,721
-4,328
-4% -$4.42M 0.59% 26
2026
Q1 		$102M Buy
111,049
+11,475
+12% +$11.6M 0.47% 34
2025
Q4 		$107M Buy
99,574
+15,974
+19% +$15.3M 0.32% 28
2025
Q3 		$63.8M Buy
83,600
+11,473
+16% +$8.54M 0.19% 56
2025
Q2 		$56.2M Sell
72,127
-8,672
-11% -$6.74M 0.34% 42
2025
Q1 		$66.7M Buy
80,799
+14,015
+21% +$11.7M 0.53% 31
2024
Q4 		$51.6M Buy
66,784
+4,595
+7% +$3.8M 0.5% 33
2024
Q3 		$55.1M Buy
62,189
+7,736
+14% +$6.96M 0.68% 28
2024
Q2 		$49.3M Buy
54,453
+5,550
+11% +$4.44M 0.66% 29
2024
Q1 		$38M Buy
48,903
+3,866
+9% +$2.75M 0.55% 29
2023
Q4 		$26.3M Buy
45,037
+3,205
+8% +$1.87M 0.44% 39
2023
Q3 		$22.5M Buy
41,832
+2,295
+6% +$1.18M 0.46% 38
2023
Q2 		$18.5M Buy
39,537
+5,615
+17% +$2.35M 0.37% 48
2023
Q1 		$11.6M Sell
33,922
-2,854
-8% -$963K 0.27% 65
2022
Q4 		$13.5M Buy
36,776
+2,930
+9% +$1.04M 0.38% 47
2022
Q3 		$10.9M Buy
33,846
+9,978
+42% +$3.16M 0.3% 56
2022
Q2 		$7.74M Buy
23,868
+4,930
+26% +$1.48M 0.23% 74
2022
Q1 		$5.42M Buy
18,938
+3,054
+19% +$786K 0.13% 102
2021
Q4 		$4.39M Buy
15,884
+1,370
+9% +$347K 0.1% 110
2021
Q3 		$3.35M Buy
14,514
+881
+6% +$217K 0.09% 130
2021
Q2 		$3.13M Buy
13,633
+3,337
+32% +$670K 0.09% 126
2021
Q1 		$1.92M Buy
+10,296
New +$2.01M 0.08% 141
2020
Q4 		– Sell
-7,041
Closed -$1.04M – 316
2020
Q3 		$1.04M Sell
7,041
-1,082
-13% -$167K 0.06% 168
2020
Q2 		$1.33M Buy
8,123
+56
+0.7% +$8.6K 0.09% 129
2020
Q1 		$1.12M Buy
8,067
+1,895
+31% +$260K 0.09% 131
2019
Q4 		$811K Buy
+6,172
New +$715K 0.07% 169

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IEQ Capital's LLY Position: Q2 2026 in Review

IEQ Capital reduced its Eli Lilly (LLY) stake by 3.9% in Q2 2026, selling an estimated $4.42M and leaving 106,721 shares worth $128M. The position accounts for 0.59% of the portfolio, ranked #26.

IEQ Capital first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • IEQ Capital held 106,721 shares of Eli Lilly worth $128M as of Q2 2026.
  • IEQ Capital sold 4,328 Eli Lilly shares in Q2 2026, an estimated $4.42M.
  • Eli Lilly made up 0.59% of IEQ Capital's portfolio in Q2 2026, its #26 holding.
  • IEQ Capital first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.